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Background: Biochemical evidence of a caspase-like execution pathway has been demonstrated in a variety of
protozoan parasites, including Blastocystis spp. The distinct differences in the phenotypic characterization reported
previously have prompted us to compare the rate of apoptosis in Blastocystis spp. isolated from individuals who
were symptomatic and asymptomatic. In the current study, we analysed the caspase activation involved in PCD
mediated by a cytotoxic drug, (metronidazole) in both symptomatic & asymptomatic isolates.
Methods: Apoptosis was induced in Blastocystis spp. by treating cultures of symptomatic and asymptomatic
isolates of 3 sub-types namely 1, 3 and 5 with two different concentrations, 0.1 and 0.0001 mg/ml of metronidazole
(with and without pre-treatment with a pan-caspase inhibitor, zVAD.fmk). The experiment was repeated to assess
the number of apoptotic cells in all the isolates of both conditions.
Results: Symptomatic isolates of subtype 3 (without pre-treatment with a pan-caspase inhibitor, zVAD.fmk) showed
high fluorescence intensity for active caspase-like proteases [0.0001 mg/ml, 88% (p < 0.001) at 0.1 mg/ml, 70%
(p < 0.001)] at the 72nd hour in vitro culture in comparison with asymptomatic isolates [0.0001 mg/ml, 65%, at
0.1 mg/ml, 55%]. The number of apoptotic cells was higher [0.0001 mg/ml, 89% (p < 0.001) and at 0.1 mg/ml, 70%
(p < 0.001)] at the 72nd hour of in vitro culture in comparison with asymptomatic isolates [0.0001 mg/ml, 66%
(p < 0.001) and at 0.1 mg/ml, 45% (p < 0.01)]. Cells treated with metronidazole in the presence of zVAD.fmk showed
less than 10% caspase activation.
Conclusion: The high number of symptomatic cells expressing active caspase-like proteases and becoming
apoptotic compared to asymptomatic cells clearly demonstrates that the response to metronidazole treatment is
isolate dependent. Hence this justifies the conflicting reports on the curative success rates when treated with this
drug. The study has also created a need to identify apoptosis effectors in Blastocystis spp of different isolates
especially as it was shown that apoptosis was sub-typed related. These findings can be exploited for the
development of diagnostic markers and novel therapeutic drugs to enhance the effectiveness of the diagnosis and
treatment of the patients infected with Blastocystis spp.
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Depending on the origin of the death stimuli, apoptotic re-
sponse could be mediated through the caspase-dependent
and an independent (involving mitochondria) pathway. The
first involves the activation of caspases (cysteine proteases
that cleave after an aspartate residue in substrates). Cas-
pases, the regular executioners of apoptosis, consist of 2* Correspondence: suresh@um.edu.my
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article, unless otherwise stated.major groups, the effectors and initiators. Though both
groups share similar general features, their mode of activa-
tion, inhibition and release of inhibition are differently reg-
ulated [1].
Cell death occurrences were also reported in the pres-
ence of the pan-caspase inhibitor zVAD.fmk, indicating
the existence of caspase independent death effectors [2].
In such studies, this caspase-independent pathway was
referred to as a mitochondrial pathway. This pathway in-
volves mitochondrial dysregulation resulting from a lossed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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pro-apoptotic proteins leading to cell death. Mitochon-
drial pro-apoptotic proteins were shown to be involved
in caspase independent pathways [3]. Both caspase-3-
like activation and mitochondrial dysregulation have
been reported to occur during apoptosis in Blastocystis
spp. although the same study also reported that, both
pathways, when blocked, could not save the parasite
from death [4].
Blastocystisspp.is an extracellular unicellular enteric
parasite with conflicting reports on its pathogenic poten-
tial. The symptoms are mainly bloating stomach, vomit-
ing, abdominal pain, as well as mucous and watery
diarrhoea [5]. Irritable bowel syndrome (IBS) [6] and
dermatological disorders [7,8] are also frequently associ-
ated with blastocystosis. It is transmitted through the
fecal oral route, and metronidazole, a cytotoxic drug is
still the treatment of choice for Blastocystis infections
despite its ineffectiveness against Blastocystis spp. being
demonstrated [9-12] These conflicting findings led us to
believe that, probably, the response towards metronida-
zole could be more isolate related involving different
mechanisms in apoptosis especially as we have already
previously established that apoptosis is subtype influ-
enced [12]. This and our previous finding of phenotypic
differences between Blastocystis spp. from symptomatic
and asymptomatic patients [13] is currently exploited
further to assess if there are differences in caspase-like
activities in parasites isolated from symptomatic and
asymptomatic isolates.
Methods
In vitro culture of parasites
A total of 7 symptomatic isolates of Blastocystis spp. 3 of
subtype 3 (st3), 2 each of subtype 1 (st1), and subtype 5
(st5) and 7 asymptomatic isolates, 3 of subtype 3 (st3), 2
each of subtype 1 (st1), and subtype 5 (st5) respectively
were obtained from separate infected individuals. Screen-
ing to rule out other bacterial, viral and protozoan patho-
gens was carried out to ensure that the symptoms in
persons were only related to Blastocystis. Symptomatic pa-
tients harbouring the parasites showed diarrhoea and
bloating stomach whereas asymptomatic isolates were ob-
tained from infected persons who did not show any symp-
toms. The isolated parasites were maintained through
in vitro cultivation in Jones’ medium supplemented with
10% horse serum and incubated at 37°C [14,15]. A pea
sized stool amount was taken from every stool cup and in-
troduced into culture tubes containing 3 ml of Jones’
medium. The parasites were maintained and sub-cultured
once every 3 to 4 days for at least 1 month prior to this
study. DNA was extracted directly from the culture sam-
ples using the QIAGEN Stool Mini Kit (QIAGEN, Hilden,
Germany). Five μl of DNA preparations were used toamplify genomic sequences in 25 μl of PCR mixture. PCR
amplification for each primer pair was repeated three
times for each isolate. The isolates were then subjected to
sequenced-tagged site (STS) primer-polymerase chain re-
action (PCR) using seven sets of primers, namely, 351 bp
for subtype 1, 526 bp for subtype 3 and 317 bp for subtype
5 [16].
Induction of cell death via metronidazole
Metronidazole, 2-methyl-5nitroimidazole-1-ethanol, is a
5-nitroimidazole drug used for the treatment of anaer-
obic infections. Stock solutions of metronidazole (Dis-
covery Fine Chemicals, Dorset, UK) were prepared in
distilled water and further diluted to obtain the desired
concentrations. Then, 1 × 105 cells ml-1 were introduced
into a micro- centrifuge containing the final concentra-
tion of 0.0001 mg/ml & 0.1 mg/ml of the drug in 1.5 ml
micro centrifuge tube (Axygen Biosciences, Union City,
California, USA). For caspase inhibition assays, 25 μM of
pan-caspase inhibitor, zVAD.fmk (Z-Val-Ala-Asp.fluoro-
methylketone) (Pharmingen) was added to the culture
medium 15 min before drug treatment. Micro- centrifuge
tubes containing the same amount of parasites but un-
treated served as controls. Cells were then harvested at
12, 24, 36, 48, 60, 72, 84 and 96 hours for epifluorescence
microscopy analysis for cytochemical assay & cell diam-
eter measurement.
Cytochemical staining method
FAM FLICA ™ CaspaTag CASPASE 3/7 Kit
Harvested cells were washed twice with 1 ml of PBS at
pH 7.4. The cells were then pooled and centrifuged
(2000 × g 5 min). Next, the cells were stained with FAM
FLICA™ CaspaTag CASPASE 3/7 Kit (Chemicon) ac-
cording to manufacturer’s protocol. The cells were ex-
amined using an epifluorescence microscope (Leitz,
Wetzlar, Germany) under x400 magnification incident
light transmission and the images were captured using
an image analyser. The quantitative analysis of staining
intensities of the cells were determined by calculating
the percentage of cells stained with FAM FLICA™ Cas-
paTag CASPASE 3/7 kit and their respective fluorescent
intensity in 100 randomly selected cells for each tube.
The fluorescent intensity was expressed as arbitrary
fluorescent units (AFU) and then reflected in the fol-
lowing manner: 1+, weak (dull green); 2+, medium
(green); 3+, strong (bright green). Apoptotic cells fluor-
esce green. As apoptosis progresses, the number of cells
undergoing active caspase increases. Cells in advanced
stages of apoptosis appear brighter green.
Detection of apoptotic and late apoptotic forms
The detection of apoptotic and necrotic cells was carried
out using Apoptosis, Necrotic & Healthy Cells Qualification
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washed twice with 1 ml of PBS at pH 7.4. Then, 1x binding
buffer, 200 μM EthidiumHomodimer (III) (200 μM in PBS),
FITC-Annexin V (250 μL in TE buffer containing 0.1%
BSA and 0.1% NaN3 at pH 7.5) and Hoechst 33342
(500 μg/mL in PBS) were added sequentially. Samples were
then observed under an epifluorescence microscope (Leitz,
Wetzlar, Germany) using imageanalyser software. Results of
cells undergoing apoptosis and necrosis were quantified
with regard to percentage of apoptotic and necrotic cells in
100 cells.
Viability of cells via cell counting
Each time the cells were harvested, viability of the cells
were determined quantitatively via the trypan blue dye ex-
clusion method and Neubauerhemocytometer chamber
(Hausser Scientific, Horsham, Pennsylvania, USA). 10 μl
of the cells were mixed thoroughly with 10 μl of the dye
and allowed to stand for 5 min at 15°C to 30°C. Cells that
were stained and unstained were e enumerated as non-
viable and viable respectively [15].
This study was approved by the Medical Ethics Com-
mittee of the University Malaya Medical Centre (UMMC)
Kuala Lumpur, Malaysia according to the Declaration of
Helsinki.
Statistical analysis
Statistical analysis was carried out using SPSS Statistics
18.0 software (SPSS Inc. Chicago, Illinois, USA). Inde-
pendent Student’s t-test was used to assess the relation-
ship of cells undergoing apoptosis in different subtypes.
Correlation tests as appropriate were used to assess the
correlation value between cells undergoing apoptosis
and late stage apoptosis and number of cells in granular
forms between different subtypes. P < 0.05 was consid-
ered statistically significant. Every experiment was con-
ducted in triplicates.
Results
Cells expressing caspase-like activity
Caspase-like activation, an early event in apoptosis, was
detected in all the symptomatic and asymptomatic isolates
of both conditions (treated and untreated) [Figure 1a-d)]
(without pre-treatment with a pan-caspase inhibitor,
zVAD.fmk). At the 72 hr, [Figure 1c], 89% of treated symp-
tomatic cells of subtype 3 showed significantly (p < 0.001)
high fluorescence intensity for active caspase-like prote-
ases of cells in comparison with only 75% of cells stained
in untreated symptomatic subtype 3. Whereas, in the
treated asymptomatic isolates [Figure 1d], 65% of the cells
showed fluorescence intensity for active caspase-like pro-
teases and 20% of apoptotic cells in the untreated asymp-
tomatic isolates. Subtype 3 appears to have the highest
number of cells expressing caspase-like activity in bothsymptomatic and asymptomatic isolates. But, in the un-
treated condition, [Figure 1a and b], number of cells that
showed fluorescence intensity for active caspase-like
proteases for both symptomatic and asymptomatic iso-
lates decreased with time without significant differences
between them. Hence the significance appears obvious,
only after treatment, with subtype 3 showing the highest
elevation of caspase-like proteases. Treated and un-
treated cells in the presence of pan-caspase inhibitor,
zVAD.fmk showed less than 10% caspase activation (data
not shown).
Apoptotic and granular forms
All the cells that were apoptotic appeared granular under
bright field [Figure 2 (a & b)-A] and stained positive for
apoptosis using FITC Annexin (V) [Figure 2 (a & b)-C].
Symptomatic isolates of subtype 3 showed a higher num-
ber of granular forms at the 72nd hour of in vitro culture
in comparison with other asymptomatic isolates at the
same hour namely subtypes 1, 3 and 5 where at 0.0001 mg/
ml, 81% (p < 0.001) and at 0.1 mg/ml, 70% (p < 0.01) of cells
were granular. Only 68% of cells were apoptotic and granu-
lar in subtype 1, 65% in subtype 3 and 60% in subtype 5.
Apoptotic and viable forms
In the untreated condition [Figure 3a] the number of
apoptotic cells (stained blue and green) in the asymptom-
atic isolates was significantly higher (p < 0.01) in com-
parison with symptomatic isolates. High significant
elevation of apoptotic forms [Figure 3b] were observed at
the 72nd hour in the symptomatic isolates in comparison
with asymptomatic ones in the treated condition. Both
dosages of drug show significant (p < 0.001 and p < 0.01)
results in the apoptosis rate and the number of viable
forms of the parasite. The number of viable apoptotic
cells of the symptomatic isolates was higher in the treated
condition [Figure 3d] than in the untreated condition
[Figure 3c]. There is a clear correlation between viable
and apoptotic cells of the symptomatic isolates. Drug
treated cells showed a high correlation value (r = 0.932)
for cells treated with 0.0001 mg/ml and (r = 0.899) cells
treated with 0.1 mg/ml of the drug. Whereas, in asymp-
tomatic isolates, the correlation value for cells treated
with 0.0001 mg/ml (r = 0.799) and (r = 0.789) for 0.1 mg/
ml of the drug. However, there was no significant correl-
ation obtained between viable and apoptotic cells of the
untreated symptomatic and asymptomatic isolates.
Discussion and conclusion
We have reported in the past that treated Blastocystis
spp. showed a significant decrease in diameter, in com-
parison with the untreated isolates [12]. In the intrinsic
pathway of apoptosis), mitochondrial membranes will be
depolarised causing the release of cytochrome c into the
Figure 1 Rate of caspase-like activity (without pre-treatment with a pan-caspase inhibitor, zVAD.fmk). (a) untreated symptomatic
(b) untreated asymptomatic isolates of Blastocystis spp. (c) treated (0.0001 mg/ml) symptomatic and (d) treated (0.0001 mg/ml) asymptomatic
isolates of Blastocystis spp.
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of mitochondrial proapoptotic events during apoptosome
[17]. Dimerization of procaspase-9 molecules at Apaf-1
scaffold causes activation of caspase-9 [18]. Once initi-
ator activated, they proteolytically activate the effector
procaspases-3, -6, and -7 which subsequently cleave a
specific set of protein substrates, including procaspasesFigure 2 Images of Blastocystis spp. stained using Hoechst stain (blue
Blastocystis cells from subtype 3 and 2 (b) represents cells from subtype 1
Blastocystisspp. (B) Blastocystisspp stained with Hoechst stain (blue) (C) Blas
with EthidiumHomodimer (III) (red). Annexin V labeled with fluorescein (FIT
membrane of Blastocystis spp. EthD-III is a highly positively charged nucleic
stains late apoptotic-necrotic cells. (A: Apoptotic).themselves, resulting in the start-up and amplification of
the death signal. Execution of cell death will then take
place with all the morphological and biochemical features
usually observed [19]. The present study despite using
a broad spectrum caspase inhibitor, zVAD.fmk, still
showed caspase –like activity demonstrating possible
involvement of uncharacterized caspase-like proteases), FITC Annexin (V), and EthidiumHomodimer (III). (a) represents
(A) light microscopy images showing drug treated (0.0001 mg/ml)
tocystisspp stained with Annexin (V) (green) (D) Blastocystisspp stained
C) identify apoptotic cells by binding to PS exposed on the outer
acid probe, which is impermeant to live cells or apoptotic cells but
Figure 3 Apoptotic and viability rate of both treated and untreated Blastocystis spp. (Without pre-treatment with a pan-caspase inhibitor,
zVAD.fmk) (a) apoptotic rate of untreated forms (b) treated forms (0.0001 mg/ml) of Blastocystisspp. (c) viability rate of untreated forms and
(d) treated forms (0.0001 mg/ml) of Blastocystisspp.
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reported by Nasirudeen [20] and the possible role of
for mitochondria in Blastocystis spp as many studies
have reported that mitochondrial dysregulation could
trigger caspase-independent apoptosis [4].
The occurrences of programmed cell death without the
presence of caspases have been reported in few recent
studies [21]. Caspase-independent cell death is usually
linked to paraptosis, authophagy, or non-lysosomal cell
death [21]. Moreover, MOMP (mitochondria membrane
potential) controlled by Bcl-2 family proteins resides at
the heart of several alternative cell death pathways [22].
Even though, more reports of non-classical apoptosis are
emerging today, ours is the first study to look at the rate
of caspase dependent and independent pathways involving
symptomatic and asymptomatic pathways. High fluores-
cence intensity for active caspase-like proteases of cells in
the symptomatic isolates, especially of those belonging to
subtype 3, possess a higher sensitivity to metronidazole
triggering a possible underlying mechanism when exposed
to the drug. Metronidazole (inactivated form) enters into
the mitochondria of cells through passive diffusion. The
selective cytotoxicity of metronidazole relies on biochem-
ical properties of pathogens that are lacking in aerobic
cells of eukaryotic hosts harbouring them. Conversion of
cells from the inactive to active form leads to further up-
take of the inactive form. Thus, the rate of intracellular ac-
tivation is important as it affects drug uptake via a
concentration gradient [23]. Once inside, the drug com-
petes with the natural electron transport system of theorganism. The organism then transfers electrons to the ni-
tro group of the drug [24]. This reduction causes the drug
to release cytotoxic radicals, thus killing the cell [24]. This
raises the possibility that the drug sensitivity could be
more enhanced in symptomatic isolates due to the higher
rate of intracellular activation in the symptomatic isolates,
thus resulting in an increased uptake of drug before trans-
ferring their own electrons to the nitro group of the drug.
This could have increased the rate of apoptosis in the
symptomatic isolates.
Untreated isolates of both the symptomatic and asymp-
tomatic group, too, underwent apoptosis but at a lower
rate compared to treated cells. This is because in normal
cultures, especially after sub-culture, parasites do tend to
be apoptotic naturally as the process of cell death is an
intrinsic part of the parasite’s life cycle.
Blastocystis spp. in symptomatic patients could have
made infected individuals seek treatment. It is uncertain
whether such treatment significantly altered the bio-
chemical aspects of the parasite which in turn when ex-
posed to metronidazole in the present study could have
caused higher sensitization of the caspase pathway. In
this study, despite inhibiting the caspase pathways the
subtype 3 of the symptomatic isolates showed the high-
est number of cells becoming apoptotic in comparison
with the asymptomatic isolates.
Previously we have shown that symptomatic isolates
have a lower growth rate compared to asymptomatic iso-
lates which is probably attributed to the higher apoptotic
activity in the symptomatic isolates [13].
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which are apoptotic were observed to be granular in na-
ture concurring with the observation by Haresh [25] that
the treated parasites could have reverted to granular
forms as a survival mechanism to release reproductive
granules and thus increase the number of parasites in
cultures. It is highly likely that the initial stage of apop-
tosis seen by the high caspase-like activity triggers a
regulatory mechanism of survival for the cells to be
granular. Hence this justifies the correlation between
apoptotic and the numbers of viable cells providing evi-
dence that the process of apoptosis in Blastocystis spp.,
while leading to cell death could also trigger a regulatory
mechanism for cell survival. Upon drug exposure, the
cell effectors (already activated by apoptotic receptors)
could have signalled the reproduction mechanism to pro-
duce more granules. Most probably, it is the cell number
of the parasite that them pathogenic. Perhaps this is why,
as the apoptosis rate increases, the cells which are be-
coming viable in symptomatic isolates are significantly
higher in comparison with isolates from the asymptom-
atic ones. Thus, as reported previously, cell death mecha-
nisms were allegedly adapted over time, congruent not
with their emergence, but, their regulation. The present
study justifies what Taylor-Brown and Hurd [26] recently
stated; that there is no such thing as a bona fide cell
death programme. It is most likely that, from the early
stage of cellular life, that both the cell differentiation and
cell cycle processes had intrinsic error rates that would
have needed regulation to avoid destruction of the cell
[26]. Ameisen [27] continued with this idea, by suggest-
ing that the genes involved with the cell processes would
have evolved in conjunction with the genes associated
with error rate-limiting control mechanisms. In fact,
there have been many studies reporting that most genes
involved in metazoan cell death programmes can be seen
to have other primary functions. Protozoa lacks most of
the molecules involved in apoptotic death of multicellular
organisms [28]. The presence of caspase-like protease indi-
cates that there are some molecular similarities between
apoptosis of higher animals and protozoans. This warrants
further research on the apoptotic machinery of the parasitic
protozoa. The need for elucidating the association between
the mode of the drug and the biochemical pathways in-
volved in apoptosis or non-classical apoptosis after drug
exposure needs to be exploited for the development of
novel therapeutic drugs and diagnostic markers.
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